Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

Oramed Pharmaceuticals (ORMP) Institutional Ownership

Oramed Pharmaceuticals logo
$3.99 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$3.85 -0.14 (-3.56%)
As of 05/22/2026 07:31 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Oramed Pharmaceuticals (NASDAQ:ORMP)

Current
Institutional Ownership
Percentage
12.73%
Number of
Institutional Buyers
(last 12 months)
16
Total
Institutional Inflows
(last 12 months)
$8.05M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$1.39M
Get ORMP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ORMP Institutional Buying and Selling by Quarter

Oramed Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/19/2026 Bank of America Corp DE146,152$497K0.0%+2.7%0.361%
5/15/2026 OMERS ADMINISTRATION Corp18,400$63K0.0%N/A0.045%
5/7/2026 Dimensional Fund Advisors LP158,209$538K0.0%+5.1%0.391%
5/5/2026 Hillsdale Investment Management Inc.97,300$331K0.0%N/A0.241%
4/28/2026 Kathmere Capital Management LLC15,071$51K0.0%N/A0.037%
4/20/2026 Ritholtz Wealth Management155,479$529K0.0%N/A0.384%
3/6/2026 Redwood Family Wealth LLC23,000$66K0.1%N/A0.058%
2/20/2026SB Capital Management Inc1,900,000$5.42M2.0%N/A4.774%
2/18/2026 XTX Topco Ltd38,182$109K0.0%+59.9%0.096%
2/18/2026 Quadrature Capital Ltd41,734$119K0.0%N/A0.105%
2/18/2026 Boothbay Fund Management LLC612,160$1.75M0.0%-27.6%1.538%
2/16/2026 Squarepoint Ops LLC58,272$166K0.0%+95.1%0.146%
2/13/2026 Marshall Wace LLP259,055$738K0.0%N/A0.651%
2/12/2026 Jane Street Group LLC78,259$223K0.0%+31.2%0.197%
2/12/2026 HRT Financial LP46,091$131K0.0%N/A0.116%
11/17/2025 Susquehanna International Group LLP36,825$97K0.0%-48.7%0.090%
11/17/2025 Bank of America Corp DE149,667$395K0.0%+4.4%0.365%
11/14/2025 Squarepoint Ops LLC29,866$79K0.0%-35.2%0.073%
11/12/2025 Dimensional Fund Advisors LP147,487$389K0.0%-11.6%0.360%
11/10/2025 BML Capital Management LLC3,167,231$8.36M6.4%+2.7%7.724%
8/15/2025 Bank of America Corp DE143,406$323K0.0%-12.4%0.351%
8/14/2025 Jane Street Group LLC42,367$95K0.0%-36.9%0.104%
8/11/2025 BML Capital Management LLC3,083,253$6.94M5.2%+2.1%7.548%
8/7/2025 Connor Clark & Lunn Investment Management Ltd.60,449$136K0.0%-30.6%0.148%
7/31/2025 Peapod Lane Capital LLC84,779$191K0.2%-66.4%0.208%
7/10/2025 Wealth Enhancement Advisory Services LLC18,799$41K0.0%+36.2%0.046%
5/19/2025Jane Street Group LLC67,173$144K0.0%+35.3%0.164%
5/13/2025Rathbones Group PLC236,803$507K0.0%-18.3%0.580%
5/12/2025Connor Clark & Lunn Investment Management Ltd.87,136$186K0.0%-18.6%0.213%
5/7/2025N.E.W. Advisory Services LLC18,900$40K0.0%+52.9%0.046%
5/7/2025BML Capital Management LLC3,020,748$6.46M5.0%+14.3%7.395%
4/30/2025Peapod Lane Capital LLC252,224$540K0.6%+11.0%0.617%
2/17/2025Squarepoint Ops LLC54,439$132K0.0%-34.7%0.135%
2/17/2025Two Sigma Investments LP110,378$267K0.0%-22.1%0.274%
2/17/2025Two Sigma Advisers LP241,400$584K0.0%-5.6%0.599%
2/17/2025Millennium Management LLC24,381$59K0.0%-47.8%0.060%
2/17/2025Bank of America Corp DE167,653$406K0.0%-2.6%0.416%
2/14/2025Jane Street Group LLC49,663$120K0.0%-14.8%0.123%
2/14/2025Boothbay Fund Management LLC845,188$2.05M0.1%+2.0%2.097%
2/14/2025Dimensional Fund Advisors LP118,995$288K0.0%+143.8%0.295%
Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)

Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.tc pixel

Discover the real reason behind the Iran strikes before markets react
2/13/2025Renaissance Technologies LLC151,808$367K0.0%-38.1%0.377%
2/11/2025LPL Financial LLC17,431$42K0.0%-54.9%0.043%
2/7/2025BML Capital Management LLC2,643,907$6.40M4.0%+20.9%6.559%
2/4/2025World Equity Group Inc.20,000$48K0.0%N/A0.050%
1/29/2025Peapod Lane Capital LLC227,239$550K0.5%N/A0.564%
1/14/2025Marquette Asset Management LLC33,311$81K0.0%N/A0.083%
11/15/2024XTX Topco Ltd24,716$60K0.0%+59.7%0.061%
11/15/2024Murchinson Ltd.1,708,879$4.17M1.1%+0.5%4.239%
11/8/2024Connor Clark & Lunn Investment Management Ltd.111,519$272K0.0%N/A0.274%
11/5/2024BML Capital Management LLC2,186,191$5.33M3.1%+62.1%5.362%
8/16/2024Murchinson Ltd.1,699,990$4.37M0.7%+23.2%4.184%
8/14/2024Squarepoint Ops LLC81,758$210K0.0%-8.3%0.201%
8/14/2024Murchinson Ltd.874,992$2.25M0.4%-36.6%2.154%
8/12/2024XTX Topco Ltd15,474$40K0.0%N/A0.038%
8/9/2024Renaissance Technologies LLC230,800$593K0.0%+89.0%0.568%
8/9/2024Dimensional Fund Advisors LP31,470$81K0.0%+52.1%0.077%
5/20/2024Virtu Financial LLC23,165$68K0.0%N/A0.057%
5/16/2024Murchinson Ltd.1,379,495$4.03M0.3%+31.4%3.395%
4/24/2024Assenagon Asset Management S.A.18,659$54K0.0%N/A0.046%
4/23/2024BML Capital Management LLC844,496$2.47M1.6%-33.1%2.084%
1/30/2024BML Capital Management LLC1,261,559$2.91M2.2%+61.5%3.127%
11/13/2023Algert Global LLC14,680$38K0.0%N/A0.036%
11/13/2023Rathbones Group PLC289,803$756K0.0%N/A0.718%
11/7/2023Barclays PLC18,406$47K0.0%+39.0%0.046%
11/6/2023N.E.W. Advisory Services LLC12,960$34K0.0%N/A0.032%
10/23/2023BML Capital Management LLC781,292$2.04M1.9%-8.1%1.940%
9/21/2023Barclays PLC13,239$47K0.0%-35.9%0.033%
8/7/2023Acadian Asset Management LLC31,736$113K0.0%N/A0.079%
7/26/2023Glass Jacobson Investment Advisors llc12,255$44K0.0%N/A0.031%
7/24/2023BML Capital Management LLC850,000$3.04M2.7%-37.3%2.123%
5/12/2023Corsair Capital Management L.P.47,256$103K0.0%N/A0.119%
4/18/2023ETF Managers Group LLC68,940$150K0.0%N/A0.173%
4/14/2023BML Capital Management LLC1,355,925$2.96M2.6%N/A3.409%
2/14/2023683 Capital Management LLC20,537$247K0.0%N/A0.052%
2/13/2023GSA Capital Partners LLP46,039$554K0.1%N/A0.118%
2/9/2023Landscape Capital Management L.L.C.26,220$315K0.0%N/A0.067%
2/9/2023Citigroup Inc.65,890$793K0.0%+115.0%0.168%
2/8/2023Belpointe Asset Management LLC29,900$360K0.0%N/A0.076%
2/8/2023Russell Investments Group Ltd.56,516$680K0.0%N/A0.144%
2/6/2023Glass Jacobson Investment Advisors llc9,350$112K0.1%N/A0.024%
2/1/2023Private Portfolio Partners LLC53,600$645K0.2%-20.5%0.137%
2/1/2023Janney Montgomery Scott LLC12,379$149K0.0%N/A0.032%
1/26/2023Calamos Advisors LLC14,746$177K0.0%N/A0.038%
1/25/2023Lindbrook Capital LLC383,351$4.61M0.6%N/A0.980%
1/18/2023Private Advisor Group LLC11,794$142K0.0%N/A0.030%
11/15/2022ETF Managers Group LLC94,493$612K0.0%+8.2%0.242%
11/14/2022Cubist Systematic Strategies LLC117,477$761K0.0%+66.1%0.303%
11/14/2022Ergoteles LLC24,149$156K0.0%-89.3%0.062%
11/10/2022Phoenix Holdings Ltd.13,634$89K0.0%-73.2%0.035%
11/7/2022Virtu Financial LLC21,526$139K0.0%-19.3%0.055%
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company (Ad)

We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel

👉 Unlock the ticker now and get it completely free.
11/7/2022Private Portfolio Partners LLC67,400$437K0.1%+24.8%0.174%
11/3/2022Barclays PLC21,543$140K0.0%+8.7%0.055%
10/31/2022SG Americas Securities LLC10,370$67K0.0%-77.7%0.027%
10/21/2022Morgan Jess S & Co. Inc.366,401$2.37M2.1%+16.2%0.944%
10/17/2022Cambridge Investment Research Advisors Inc.14,184$92K0.0%+26.8%0.037%
8/15/2022Laurion Capital Management LP12,393$57K0.0%N/A0.032%
8/13/2022Virtu Financial LLC26,661$122K0.0%N/A0.069%
8/11/2022Bank of Montreal Can249,200$1.35M0.0%N/A0.646%
8/8/2022Oppenheimer & Co. Inc.50,000$229K0.0%+5.4%0.130%
8/2/2022Private Portfolio Partners LLC54,010$247K0.1%+27.8%0.140%


ORMP Institutional Ownership - Frequently Asked Questions

During the previous two years, 30 institutional investors and hedge funds held shares of Oramed Pharmaceuticals. The most heavily invested institutionals were BML Capital Management LLC ($8.36M), SB Capital Management Inc ($5.42M), Murchinson Ltd. ($4.17M), Boothbay Fund Management LLC ($1.75M), Marshall Wace LLP ($738K), Two Sigma Advisers LP ($584K), and Dimensional Fund Advisors LP ($538K).Learn more on Oramed Pharmaceuticals' institutional investors.

12.73% of Oramed Pharmaceuticals' stock is owned by institutional investors. Learn more on ORMP's institutional investor holdings.

Of the 24 institutional investors that purchased Oramed Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: SB Capital Management Inc ($1.90M), BML Capital Management LLC ($1.82M), Murchinson Ltd. ($329.38K), Marshall Wace LLP ($259.06K), Peapod Lane Capital LLC ($252.22K), Ritholtz Wealth Management ($155.48K), and Connor Clark & Lunn Investment Management Ltd. ($111.52K).

Institutional investors have bought a total of 2,786,824 shares in the last 24 months. This purchase volume represents approximately $8.05M in transactions.

The following institutional investors have sold Oramed Pharmaceuticals stock in the last 24 months: Boothbay Fund Management LLC ($233.23K), Peapod Lane Capital LLC ($167.45K), Susquehanna International Group LLP ($35.00K), Connor Clark & Lunn Investment Management Ltd. ($26.69K), Jane Street Group LLC ($24.81K), Bank of America Corp DE ($20.29K), and Dimensional Fund Advisors LP ($19.41K).

Institutional investors have sold a total of 543,077 shares in the last 24 months. This volume of shares sold represents approximately $1.39M in transactions.



This page (NASDAQ:ORMP) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners